Recombinant multi-species WNT11 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WNT11 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It encodes a protein which shows 97%, 85%, and 63% amino acid identity with mouse, chicken, and Xenopus Wnt11 protein, respectively. This gene may play roles in the development of skeleton, kidney and lung, and is considered to be a plausible candidate gene for High Bone Mass Syndrome. [provided by RefSeq, Jul 2008]
The Alternative Names of target: HWNT11,Protein Wnt-11,WNT11,Wnt11
Go
to WNT11 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0556-Ag-1/ GM-Tg-hg-SE0556-Ag-2 | Human WNT11 protein | Human |
| GM-Tg-rg-SE0556-Ag-1/ GM-Tg-rg-SE0556-Ag-2 | Rat WNT11 protein | Rat |
| GM-Tg-mg-SE0556-Ag-1/ GM-Tg-mg-SE0556-Ag-2 | Mouse WNT11 protein | Mouse |
| GM-Tg-cynog-SE0556-Ag-1/ GM-Tg-cynog-SE0556-Ag-2 | Cynomolgus/Rhesus macaque WNT11 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0556-Ag-1/ GM-Tg-felg-SE0556-Ag-2 | Feline WNT11 protein | Feline |
| GM-Tg-cang-SE0556-Ag-1/ GM-Tg-cang-SE0556-Ag-2 | Canine WNT11 protein | Canine |
| GM-Tg-bovg-SE0556-Ag-1/ GM-Tg-bovg-SE0556-Ag-2 | Bovine WNT11 protein | Bovine |
| GM-Tg-equg-SE0556-Ag-1/ GM-Tg-equg-SE0556-Ag-2 | Equine WNT11 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE0556-Ag-1/ GM-Tg-hg-SE0556-Ag-2;
GM-Tg-rg-SE0556-Ag-1/ GM-Tg-rg-SE0556-Ag-2;
GM-Tg-mg-SE0556-Ag-1/ GM-Tg-mg-SE0556-Ag-2; GM-Tg-cynog-SE0556-Ag-1/ GM-Tg-cynog-SE0556-Ag-2; GM-Tg-felg-SE0556-Ag-1/ GM-Tg-felg-SE0556-Ag-2; GM-Tg-cang-SE0556-Ag-1/ GM-Tg-cang-SE0556-Ag-2; GM-Tg-bovg-SE0556-Ag-1/ GM-Tg-bovg-SE0556-Ag-2; GM-Tg-equg-SE0556-Ag-1/ GM-Tg-equg-SE0556-Ag-2 |
| Products Name | WNT11 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | WNT11 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WNT11 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.